Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors. (Record no. 16125568)

MARC details
000 -LEADER
fixed length control field 01365 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515015935.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200604s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1389-4501
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2174/138945006776054997
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Vassilev, Alexei O
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060420
245 00 - TITLE STATEMENT
Title Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Current drug targets
Date of publication, distribution, etc. Mar 2006
300 ## - PHYSICAL DESCRIPTION
Extent 327-43 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Agammaglobulinaemia Tyrosine Kinase
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Autoimmune Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 1
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Delivery Systems
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Design
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Janus Kinase 3
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organ Transplantation
General subdivision physiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein-Tyrosine Kinases
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tibbles, Heather E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name DuMez, Darin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Venkatachalam, Taracad K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Uckun, Fatih M
773 0# - HOST ITEM ENTRY
Title Current drug targets
Related parts vol. 7
-- no. 3
-- p. 327-43
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2174/138945006776054997">https://doi.org/10.2174/138945006776054997</a>
Public note Available from publisher's website

No items available.